187 related articles for article (PubMed ID: 11092273)
1. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha,24-dihydroxyvitamin D3).
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2000 Oct; 27(10):669-72. PubMed ID: 11092273
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of subcorneal pustulosis (Sneddon-Wilkinson disease) with tacalcitol].
Mühlhoff C; Megahed M
Hautarzt; 2009 May; 60(5):369-70. PubMed ID: 19367371
[TBL] [Abstract][Full Text] [Related]
3. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
4. First case report of topical tacalcitol for vitiligo repigmentation.
Amano H; Abe M; Ishikawa O
Pediatr Dermatol; 2008; 25(2):262-4. PubMed ID: 18429797
[TBL] [Abstract][Full Text] [Related]
5. Subcorneal pustular dermatosis in the pediatric age.
Jardim MML; Diniz TACB; Cunha TAC; Valente NYS
An Bras Dermatol; 2018; 93(1):116-118. PubMed ID: 29641711
[TBL] [Abstract][Full Text] [Related]
6. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,24-dihydroxyvitamin D3 (tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro.
Aoki T; Hashimoto H; Koseki S; Hozumi Y; Kondo S
Br J Dermatol; 1998 Nov; 139(5):897-901. PubMed ID: 9892963
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2003 Nov; 30(11):801-4. PubMed ID: 14684937
[TBL] [Abstract][Full Text] [Related]
9. Pentoxyfilline as a treatment for subcorneal pustular dermatosis.
Falcone LM; Pilcher MF; Kovach RF; Powers R
Dermatol Ther; 2019 Mar; 32(2):e12818. PubMed ID: 30637905
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
13. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
Lambert J; Trompke C
Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
15. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing annular pustular psoriasis from subcorneal pustular dermatosis-A diagnostic dilemma in a 10-year-old boy.
Masison J; Adalsteinsson JA; Chang MW
Pediatr Dermatol; 2023; 40(4):698-701. PubMed ID: 36721346
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis circinata Toyama successfully treated with high-concentration tacalcitol ointment.
Abe M; Hashimoto C; Hasegawa M; Sogabe Y; Shyuto T; Ishikawa O
J Dermatol; 2005 Feb; 32(2):153-5. PubMed ID: 15906551
[No Abstract] [Full Text] [Related]
18. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
19. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
